Abstract
Cat scratch disease may occur during etanercept therapy, but there has been no report on infliximab-associated cat scratch disease. We report a case of a 23-year-old woman who developed right inguinal lymph node enlargement following a cat scratch. The patient had received infliximab therapy for spondyloarthropathy. She was successfully managed by discontinuing infliximab and by treatment with moxifloxacin and amikacin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wiedmann MW, Mössner J et al (2009) TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases. Endocr Metab Immune Disord Drug Targets 9:295–314
Hofland RW, Thijsen SF et al (2013) Tuberculosis during TNF-α inhibitor therapy, despite screening. Thorax 68:1079–1080
Schiffmann A, Pers YM, Lukas C et al (2009) Mesenteric and splenic cat-scratch disease during etanercept therapy. Rheumatology 48:1461–1462
Mathieu S, Vellin JF, Poujol D et al (2007) Cat scratch disease during etanercept therapy. Joint Bone Spine 74:184–186
Osorio F, Pedrosa A, Azevedo F et al (2014) Cat scratch disease during anti-tumor necrosis factor-alpha therapy: case report and review of literature. Int J Dermatol 53(3):e182–e183
Massei F, Gori L, Macchia P et al (2005) The expanded spectrum of bartonellosis in children. Infect Dis Clin North Am 19(3):691–711
Black JR, Herrington DA (1986) Life-threatening cat-scratch disease in an immunocompromised host. Arch Intern Med 146(2):394–396
Jain A, Sinqn JA (2013) Harms of tumor necrosis factor inhibitors in rheumatic diseases: a focused systematic review of the literature. Immunotherapy 5:265–299
Baeten D, Kruithof E, Van den Bosch F et al (2003) Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defense in the pathogenesis of the disease? Ann Rheum Dis 62:829–834
Wallis RS, Broder MS, Wong JY et al (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261–1265
Carithers HA (1985) Cat-scratch disease. An overview based on a study of 1,200 patients. Am J Dis Child 139(11):1124–1133
Rolain JM, Brouqui P, Koehler JE et al (2004) Recommendations for treatment of human infections caused by bartonella species. Antimicrob Agents Chemother 48:1921–1933
Conflict of interest
All authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, Y., Yin, G., Tan, C. et al. Cat scratch disease during infliximab therapy: a case report and literature review. Rheumatol Int 35, 911–913 (2015). https://doi.org/10.1007/s00296-014-3204-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-3204-y